介入性放射學市場機會、成長要素、產業趨勢分析及預測（2026年至2035年）

全球介入放射學市場預計到 2025 年將達到 309 億美元，到 2035 年將達到 515 億美元，年複合成長率為 5.2%。

推動市場成長的關鍵因素包括慢性病發病率上升、人口老化、影像技術的快速發展以及對微創治療方法日益成長的需求。介入放射學在腫瘤領域的應用、先進的3D和4D成像系統的整合以及影像引導治療的廣泛應用，都在推動對介入放射學解決方案的需求。影像硬體和軟體的持續改進催生了新的臨床應用，而現代血管造影術系統則提供了更高的空間和時間解析度。此外，融合影像和3D手術藍圖等其他技術能夠實現術中精準規劃和即時導航，從而提高手術成功率並減少併發症。這些創新，以及攜帶式影像系統的廣泛應用，正在擴大介入放射學在加護病房、急診和資源匱乏地區的應用範圍，進一步推動全球市場成長。

預計到2025年，醫院將佔據50.7%的市場佔有率，因為醫院能夠提供支持複雜介入手術所需的基礎設施、多學科團隊和資金投入。大規模教學醫院和運轉率高的社區醫院進行了大量需要先進影像技術、住院支援和專業知識的高級介入放射學（IR）手術。由於醫院能夠整合先進技術並在手術過程中提供重症監護支持，因此仍然是複雜介入手術的首選。

預計到2025年，介入放射診所市場規模將達到78億美元，其成長主要得益於門診病人更容易取得影像導引下的微創介入手術。專業的介入放射學診所擁有更高的病患接診能力、更專業的知識技能、更先進的影像系統和更有效率的評估流程。這不僅提升了病患的就醫便利性，也減輕了醫院的負擔，使醫療系統能夠在確保高品質治療效果的同時，更有效率地提供醫療服務。

預計到2025年，北美介入放射學市佔率將達到36%。該地區的主導地位歸功於其先進的醫療基礎設施、龐大的手術量、對尖端技術的早期應用、健全的報銷機制以及主要醫療設備製造商的集中佈局。此外，北美也受惠於高人均醫療支出、公立和私立醫療體系提供的全面保險覆蓋，以及在支持創新的同時保障病人安全的成熟法規環境。這些因素共同促成了該地區成為介入放射學解決方案的理想市場。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章業界考察

• 生態系分析
• 產業影響因素
  • 促進要素
    • 全球慢性病盛行率不斷上升
    • 醫學影像技術的進步
    • 對微創手術的需求日益成長
    • 人口老化趨勢日益加劇
  • 產業潛在風險與挑戰
    • 產品相關高成本
    • 複雜的法規環境
  • 機會
    • 利用人工智慧和機器人進行影像引導治療
    • 增加對混合手術室的投資
    • 低輻射和無輻射成像技術的發展
• 成長潛力分析
• 監管環境
  • 北美洲
  • 歐洲
  • 亞太地區
• 科技與創新趨勢
  • 當前技術趨勢
  • 新興技術
• 價值鏈分析
• 救贖方案
• 從住院治療過渡到門診治療的趨勢
• 定價分析
• 政策環境
• 波特五力分析
• PESTEL 分析
• 差距分析
• 未來市場趨勢

第4章 競爭情勢

• 介紹
• 企業矩陣分析
• 公司市佔率分析
  • 世界
  • 北美洲
  • 歐洲
  • 亞太地區
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 重大進展
  • 併購
  • 夥伴關係與合作
  • 新產品發布
  • 擴張計劃

第5章 2022-2035年按產品分類的市場估算與預測

• 血管造影術系統
• 超音波影像設備
• CT掃描儀
• 磁振造影系統
• 透視
• 切片檢查裝置
• 其他產品

第6章 按應用領域分類的市場估算與預測，2022-2035年

• 心臟病學
• 腫瘤學
• 婦科
• 產科
• 泌尿系統
• 胃腸病學
• 其他用途

7. 依最終用途分類的市場估計與預測，2022-2035 年

• 醫院
• 診所
• 門診手術中心
• 其他用途

第8章 2022-2035年各地區市場估算與預測

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Agfa-Gevaert Group
• Canon Medical Systems
• Carestream Health Inc.
• Cook
• Esaote SPA
• Fujifilm Corporation
• GE Healthcare
• Hologic, Inc.
• Koninklijke Philips
• Mindray
• Olympus Corporation
• Samsung Healthcare
• Shimadzu Corporation
• Siemens Healthineers
• Teleflex

The Global Interventional Radiology Market was valued at USD 30.9 billion in 2025 and is estimated to grow at a CAGR of 5.2% to reach USD 51.5 billion by 2035.

Market expansion is driven by several key factors, including the increasing prevalence of chronic diseases, an aging population, rapid advancements in imaging technologies, and growing demand for minimally invasive procedures. The adoption of interventional radiology in oncology, the integration of advanced 3D and 4D imaging systems, and the rising use of image-guided therapies are fueling the demand for IR solutions. Continuous improvements in imaging hardware and software are unlocking new clinical applications, while modern angiographic systems offer enhanced spatial and temporal resolution. Additional technologies, such as fused imaging and 3D procedural roadmaps, enable precise planning and real-time navigation during procedures, increasing procedural success rates and reducing complications. These innovations, combined with the availability of portable imaging systems, are expanding IR accessibility in intensive care units, emergency departments, and resource-limited settings, further driving the market's growth globally.

The hospitals segment held a 50.7% share in 2025, as hospitals provide the necessary infrastructure, multidisciplinary teams, and capital investment to support complex interventional procedures. Large academic medical centers and high-volume community hospitals perform many advanced IR procedures, particularly those requiring sophisticated imaging, inpatient support, and specialized expertise. Hospitals remain the preferred choice for complex interventions due to their ability to integrate advanced technologies and provide critical care support during procedures.

The clinics segment was valued at USD 7.8 billion in 2025, contributing to market growth by expanding outpatient access to image-guided, minimally invasive interventions. Specialized IR clinics are improving patient throughput, offering focused expertise, advanced imaging systems, and streamlined evaluation processes. This not only enhances patient convenience but also alleviates hospital burdens, enabling healthcare systems to deliver care more efficiently while maintaining high-quality outcomes.

North America Interventional Radiology Market held 36% share in 2025. The region's leadership stems from advanced healthcare infrastructure, high procedure volumes, early adoption of cutting-edge technologies, robust reimbursement frameworks, and concentration of top medical device manufacturers. North America also benefits from high per-capita healthcare spending, comprehensive insurance coverage through public and private systems, and a mature regulatory environment that supports innovation while ensuring patient safety. These factors make the region a prime market for interventional radiology solutions.

Key players in the Global Interventional Radiology Market include Agfa-Gevaert Group, Canon Medical Systems, Carestream Health Inc., Cook, Esaote SPA, Fujifilm Corporation, GE Healthcare, Hologic, Inc., Koninklijke Philips, Mindray, Olympus Corporation, Samsung Healthcare, Shimadzu Corporation, Siemens Healthineers, and Teleflex. Companies in the interventional radiology market are strengthening their foothold by investing in R&D for advanced imaging technologies, 3D/4D navigation systems, and AI-assisted procedural planning. Strategic partnerships with hospitals, clinics, and health systems enhance market reach and clinical integration. Firms are also expanding service networks and offering training programs to improve adoption and maximize equipment utilization. Focused innovation in portable and minimally invasive systems allows companies to target underserved markets. Additionally, adopting value-based solutions, flexible financing models, and cloud-enabled imaging platforms helps firms improve patient outcomes while reinforcing their competitive positioning in key regions worldwide.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Application trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic disease worldwide
    • 3.2.1.2 Technological advancements in medical imaging
    • 3.2.1.3 Increasing demand for minimally invasive procedures
    • 3.2.1.4 Growing elderly population base
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with product
    • 3.2.2.2 Complex regulatory scenario
  • 3.2.3 Opportunities
    • 3.2.3.1 AI- and robotics-enabled image-guided interventions
    • 3.2.3.2 Increasing investments in hybrid operating rooms
    • 3.2.3.3 Development of low-radiation and radiation-free imaging technologies
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Value chain analysis
• 3.7 Reimbursement scenario
• 3.8 In-patient to outpatient shift landscape
• 3.9 Pricing analysis
• 3.10 Policy landscape
• 3.11 Porter's analysis
• 3.12 PESTEL analysis
• 3.13 Gap analysis
• 3.14 Future market trends

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Angiography systems
• 5.3 Ultrasound imaging systems
• 5.4 CT scanners
• 5.5 MRI systems
• 5.6 Fluoroscopy systems
• 5.7 Biopsy devices
• 5.8 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Cardiology
• 6.3 Oncology
• 6.4 Gynecology
• 6.5 Obstetrics
• 6.6 Urology
• 6.7 Gastroenterology
• 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Clinics
• 7.4 Ambulatory surgical centers
• 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Agfa-Gevaert Group
• 9.2 Canon Medical Systems
• 9.3 Carestream Health Inc.
• 9.4 Cook
• 9.5 Esaote SPA
• 9.6 Fujifilm Corporation
• 9.7 GE Healthcare
• 9.8 Hologic, Inc.
• 9.9 Koninklijke Philips
• 9.10 Mindray
• 9.11 Olympus Corporation
• 9.12 Samsung Healthcare
• 9.13 Shimadzu Corporation
• 9.14 Siemens Healthineers
• 9.15 Teleflex